BR9609033B1 - composição e emulsão para a liberação controlada de uma substáncia. - Google Patents
composição e emulsão para a liberação controlada de uma substáncia.Info
- Publication number
- BR9609033B1 BR9609033B1 BRPI9609033-2A BR9609033A BR9609033B1 BR 9609033 B1 BR9609033 B1 BR 9609033B1 BR 9609033 A BR9609033 A BR 9609033A BR 9609033 B1 BR9609033 B1 BR 9609033B1
- Authority
- BR
- Brazil
- Prior art keywords
- substance
- composition
- controlled release
- emulsion
- hvlcm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Birds (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47845095A | 1995-06-07 | 1995-06-07 | |
US08/474,337 US5747058A (en) | 1995-06-07 | 1995-06-07 | High viscosity liquid controlled delivery system |
PCT/US1996/010055 WO1996039995A1 (en) | 1995-06-07 | 1996-06-07 | High viscosity liquid controlled delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
BR9609033A BR9609033A (pt) | 1999-12-14 |
BR9609033B1 true BR9609033B1 (pt) | 2009-08-11 |
BRPI9609033B8 BRPI9609033B8 (pt) | 2017-04-04 |
Family
ID=27044421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9609033A BRPI9609033B8 (pt) | 1995-06-07 | 1996-06-07 | composição e emulsão para a liberação controlada de uma substância. |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP1525858A1 (pt) |
JP (3) | JP4330175B2 (pt) |
CN (1) | CN1225230C (pt) |
AT (1) | ATE287673T1 (pt) |
AU (1) | AU698281B2 (pt) |
BR (1) | BRPI9609033B8 (pt) |
CA (1) | CA2222567C (pt) |
DE (1) | DE69634277T2 (pt) |
DK (1) | DK1006935T3 (pt) |
ES (1) | ES2238693T3 (pt) |
HK (1) | HK1015255A1 (pt) |
PT (1) | PT1006935E (pt) |
WO (1) | WO1996039995A1 (pt) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1525858A1 (en) * | 1995-06-07 | 2005-04-27 | Durect Corporation | High viscosity liquid controlled delivery system |
US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
US6051558A (en) * | 1997-05-28 | 2000-04-18 | Southern Biosystems, Inc. | Compositions suitable for controlled release of the hormone GnRH and its analogs |
DE59813940D1 (de) * | 1997-06-05 | 2007-04-19 | Roland Bodmeier | Multiphasensystem |
PT925789E (pt) † | 1997-12-02 | 2004-10-29 | Pfizer Prod Inc | Es oculares utilizacao de azitromicina no tratamento topico de infecco |
US6245345B1 (en) * | 1998-07-07 | 2001-06-12 | Atrix Laboratories, Inc. | Filamentous porous films and methods for producing the same |
US7056893B2 (en) | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
US6239113B1 (en) | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
JP4601100B2 (ja) * | 1999-11-08 | 2010-12-22 | 三生医薬株式会社 | マスティックの油液を内包した軟カプセル |
EP1397155B1 (en) | 2001-06-21 | 2015-09-30 | Genentech, Inc. | Sustained release formulation |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
EP1575569B1 (en) | 2002-12-13 | 2010-09-29 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
BR0317421A (pt) * | 2002-12-19 | 2005-11-08 | Alza Corp | Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável |
NZ545521A (en) * | 2003-09-23 | 2010-02-26 | Orthocon Inc | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
CN1856283A (zh) | 2003-09-23 | 2006-11-01 | 奥斯治疗有限公司 | 生物可吸收的油灰样止血植入体 |
US8603528B2 (en) | 2004-09-16 | 2013-12-10 | Abyrx, Inc. | Compositions and method for the reduction of post-operative pain |
LT2767292T (lt) | 2004-09-17 | 2016-12-12 | Durect Corporation | Palaikomosios vietinės anestezijos mišinys su saib |
DE102005002703C5 (de) | 2005-01-19 | 2013-07-04 | Heraeus Kulzer Gmbh | Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
US8871183B2 (en) | 2006-05-15 | 2014-10-28 | Zicare, Llc | Composition for promoting and maintaining oral health |
US20070292363A1 (en) | 2006-05-15 | 2007-12-20 | Tim Clarot | Method for prevention and treatment of periodontal disease |
AU2007325918B2 (en) | 2006-11-03 | 2013-10-17 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
MX354603B (es) | 2007-05-25 | 2018-03-13 | Indivior Uk Ltd | Formulaciones de transferencia sostenida de compuestos de risperidona. |
EP2011452B1 (fr) * | 2007-07-06 | 2014-04-30 | S.B.I.R. Sprl | Préparation injectable pour la réalisation d'un implant musculaire |
EP2067471B1 (en) | 2007-12-06 | 2018-02-14 | Durect Corporation | Oral pharmaceutical dosage forms |
CN102131483A (zh) * | 2008-02-08 | 2011-07-20 | 昌达生物科技公司 | 可控给药非聚合组合物 |
CN102231981A (zh) * | 2008-02-08 | 2011-11-02 | 昌达生物科技公司 | 蛋白质或肽的缓释给药组合物 |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
CN103830767A (zh) * | 2012-11-26 | 2014-06-04 | 韩冰 | 乙酸异丁酸蔗糖酯凝胶及其用途 |
WO2014144975A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
WO2014187962A1 (en) | 2013-05-24 | 2014-11-27 | Danmarks Tekniske Universitet | Gel formulations for guiding radiotherapy |
MX2016008496A (es) * | 2013-12-31 | 2017-01-11 | Pb&B Sa | Composiciones de acido graso de liberacion controlada para usarse en recontruccion corporal y formacion del cuerpo. |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
WO2016079330A1 (en) | 2014-11-21 | 2016-05-26 | Technical University Of Denmark | Gel formulations for local drug release |
MX2018014087A (es) | 2016-05-20 | 2019-06-10 | Univ Denmark Tech Dtu | Composicion de marcaje palpable. |
EP3478285A4 (en) * | 2016-06-30 | 2020-07-22 | Durect Corporation | DEPOSIT FORMULATIONS |
EA201990127A1 (ru) * | 2016-12-30 | 2020-08-18 | Дьюрект Корпорейшн | Депо-препарат |
WO2018225050A1 (en) | 2017-06-09 | 2018-12-13 | Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec) - Associação | Sucrose acetate isobutyrate-based compositions, methods and uses thereof |
CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
KR102388506B1 (ko) * | 2021-06-14 | 2022-04-20 | (주)씨앤엘디 | 유착방지용 조성물 |
JPWO2023063247A1 (pt) * | 2021-10-13 | 2023-04-20 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59210024A (ja) * | 1983-05-13 | 1984-11-28 | Taiyo Kagaku Kk | トコフエロ−ル乳化物 |
JPS62419A (ja) * | 1985-06-26 | 1987-01-06 | Shiseido Co Ltd | 脂溶性ビタミン含有水溶性剤 |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US4987893A (en) * | 1988-10-12 | 1991-01-29 | Rochal Industries, Inc. | Conformable bandage and coating material |
DK0601053T3 (da) * | 1991-08-26 | 2001-01-08 | Abbott Lab | Præparater og fremgangsmåder til den sublinguale eller bukkale indgivelse af terapeutiske midler |
IL103275A0 (en) * | 1991-10-01 | 1993-02-21 | Lilly Co Eli | Injectable extended release formulations and methods |
CA2125483A1 (en) * | 1991-12-11 | 1993-06-24 | Mary Ann Hunter | Cetylpyridinium chloride and domiphen bromide in organic solvent |
US5340572A (en) * | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
US5370864A (en) * | 1993-06-29 | 1994-12-06 | The Procter & Gamble Company | Breath protection microcapsules |
JPH0753356A (ja) * | 1993-08-16 | 1995-02-28 | Morishita Jintan Kk | 酸化され易い油性物質を内容物とするシームレスカプセルおよびその製造方法 |
JPH07112940A (ja) * | 1993-08-26 | 1995-05-02 | Takeda Chem Ind Ltd | 徐放性非経口投与製剤およびその製造方法 |
JPH09507233A (ja) * | 1993-12-29 | 1997-07-22 | マトリクス ファーマスーティカル,インコーポレイティド | 細胞増殖性疾患に罹る宿主の治療方法及び治療のための組成物 |
EP1525858A1 (en) * | 1995-06-07 | 2005-04-27 | Durect Corporation | High viscosity liquid controlled delivery system |
-
1996
- 1996-06-07 EP EP05075143A patent/EP1525858A1/en not_active Withdrawn
- 1996-06-07 CN CNB961958952A patent/CN1225230C/zh not_active Expired - Fee Related
- 1996-06-07 DK DK96921521T patent/DK1006935T3/da active
- 1996-06-07 PT PT96921521T patent/PT1006935E/pt unknown
- 1996-06-07 AU AU62731/96A patent/AU698281B2/en not_active Ceased
- 1996-06-07 DE DE69634277T patent/DE69634277T2/de not_active Expired - Lifetime
- 1996-06-07 BR BRPI9609033A patent/BRPI9609033B8/pt not_active IP Right Cessation
- 1996-06-07 EP EP96921521A patent/EP1006935B1/en not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/010055 patent/WO1996039995A1/en active IP Right Grant
- 1996-06-07 ES ES96921521T patent/ES2238693T3/es not_active Expired - Lifetime
- 1996-06-07 CA CA002222567A patent/CA2222567C/en not_active Expired - Fee Related
- 1996-06-07 JP JP50218197A patent/JP4330175B2/ja not_active Expired - Fee Related
- 1996-06-07 AT AT96921521T patent/ATE287673T1/de active
-
1999
- 1999-02-12 HK HK99100601A patent/HK1015255A1/xx not_active IP Right Cessation
-
2006
- 2006-11-09 JP JP2006304264A patent/JP2007126459A/ja active Pending
-
2009
- 2009-04-28 JP JP2009108881A patent/JP2009197018A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1996039995A1 (en) | 1996-12-19 |
PT1006935E (pt) | 2005-06-30 |
DK1006935T3 (da) | 2005-06-06 |
MX9709606A (es) | 1998-06-30 |
AU698281B2 (en) | 1998-10-29 |
JPH11507278A (ja) | 1999-06-29 |
CA2222567C (en) | 2002-01-29 |
JP4330175B2 (ja) | 2009-09-16 |
DE69634277T2 (de) | 2006-01-05 |
AU6273196A (en) | 1996-12-30 |
DE69634277D1 (de) | 2005-03-03 |
ATE287673T1 (de) | 2005-02-15 |
CN1192131A (zh) | 1998-09-02 |
JP2009197018A (ja) | 2009-09-03 |
CA2222567A1 (en) | 1996-12-19 |
BR9609033A (pt) | 1999-12-14 |
HK1015255A1 (en) | 1999-10-15 |
EP1525858A1 (en) | 2005-04-27 |
JP2007126459A (ja) | 2007-05-24 |
EP1006935A1 (en) | 2000-06-14 |
BRPI9609033B8 (pt) | 2017-04-04 |
CN1225230C (zh) | 2005-11-02 |
ES2238693T3 (es) | 2005-09-01 |
EP1006935B1 (en) | 2005-01-26 |
EP1006935A4 (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9609033B1 (pt) | composição e emulsão para a liberação controlada de uma substáncia. | |
WO1999013913A3 (en) | High viscosity liquid controlled delivery system as a device | |
BR9809189A (pt) | Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos | |
DE69612373D1 (de) | Arzneimittelhaltiges tierfutter | |
DE69803940D1 (de) | Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe | |
MX170784B (es) | Composicion cosmetica que contiene diorganopolisiloxanos con funcion benzotriazol para la proteccion de la piel y el cabello | |
BG102469A (en) | Cleaning composition for personal hygiene | |
MX9100423A (es) | Composiciones liquidas y estabilizadas para el tratamiento de la piel y fibras | |
DK647789D0 (da) | Kosmetisk eller farmaceutisk komposition indeholdende mikrosfaerer af polymere eller af fedtstofferforsynet med mindst et aktivt produkt | |
BR0105456A (pt) | Dispositivo de condicionamento comportando uma unidade | |
PT774962E (pt) | Utilizacao de dha como uma composicao farmaceutica | |
MX9307256A (es) | Dispositivo de administracion que tiene excipientes capsulados. | |
KR890000085A (ko) | 필수지방산 합성물(Essential Fatty Acid Compositions) | |
ATE154235T1 (de) | Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten | |
KR900007424A (ko) | 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물 | |
ES2141736T3 (es) | Gel, especialmente para uso terapeutico ocular. | |
DK1178854T3 (da) | Indretning til transkutan indgivelse af molekyler indeholdt i et relativt viskost bærerstof, såsom en gel eller lignende | |
DE69302580D1 (de) | Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung | |
KR850000968A (ko) | 피부 보호 조성물의 제조 방법 | |
ES2090969T3 (es) | Composicion inyectable que contiene microcapsulas de colageno. | |
JPS57209217A (en) | Medicament preparation | |
MX9302986A (es) | Medicamento que contiene metrifonato y procedimiento para su preparacion | |
DE59801586D1 (de) | Zur topischen applikation bestimmte diclofenac-lösung | |
KR890001567A (ko) | 디플루니살 및 트로메타민-함유 조성물 | |
SU1830659A1 (ru) | Состав дератизационного покрытия |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD5 | Application fees: dismissal - article 86 of industrial property law | ||
HIX | Notification cancelled | ||
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE PATENTE COM BASE NO ARTIGO 24 DA LPI NO 9.279 DE 14/05/1996. |
|
B25A | Requested transfer of rights approved |
Owner name: DURECT CORPORATION (US) Free format text: TRANSFERIDO POR FUSAO DE: SOUTHERN BIOSYSTEMS, INC. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09Y | Publication of grant cancelled [chapter 9.1.2 patent gazette] |
Free format text: REFERENTE A RPI 1982 DE 30/12/2008. |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-524000.061598/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132260-18.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: D. WESTERN THERAPEUTICS INSTITUTE, KOWA COMPANY, LTD., DURECT CORPORATION, ELANCO ANIMAL HEALTH IRELAND LIMITED, EUROVITA A/S, EVONIK GOLDSCHMIDT GMBH |
|
B19A | Notification of judicial decision: notification of judicial decision | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] | ||
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 07/06/2016 |